Status:
COMPLETED
Potential Harms of Untargeted Iron Supplementation in Cambodia Where Iron Deficiency is Not the Cause of Anemia
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
Helen Keller International
NCHADS - Ministry of Health of Cambodia
Conditions:
Anemia, Iron Deficiency
Anemia
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
In 2016, the World Health Organization (WHO) set a global policy recommending daily oral iron supplementation (60 mg iron) for 12 weeks for all women living in countries where anemia prevalence is \>4...
Detailed Description
The World Health Organization (WHO) set a Global Nutrition Target to reduce anemia in women of reproductive age by 50% by 2025. In 2016, the WHO implemented a global policy recommending oral iron supp...
Eligibility Criteria
Inclusion
- apparently healthy
- consent to participate in the study and provide blood, flocked rectal swab and stool samples
- expected to reside in the study location for the study period.
Exclusion
- any known illness or disease
- pregnant
- taking antibiotics, non-steroidal anti-inflammatory drugs, dietary supplements, or vitamin and mineral supplements in the previous 12 weeks.
Key Trial Info
Start Date :
December 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT04017598
Start Date
December 10 2019
End Date
December 1 2023
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prey Kuy, Srayov and Tboung Krapeu Health Centres
Kampong Thom, Cambodia